Stocktoria

Lunai Bioworks Inc. LNAI

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-11-18 · LEI

Lunai Bioworks Inc. statistics & valuation

Market cap$14.6M
Net margin-6852.0%
FCF margin-10173.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-6852.00% 2017201820192020202120222023202420252026
Gross margin (%)
2017201820192020202120222023202420252026
Operating margin (%)
-16729.40% 2017201820192020202120222023202420252026
Return on equity (%)
-139.80% -4.00% -10.40% -6.90% -15.30% -156.20% -85.30% -67.00% 2017201820192020202120222023202420252026
Shares outstanding
12.4M 36.2M 45.3M 46.5M 52.2M 53.0M 63.7M 158.5M 2.2M 4.6M 2017201820192020202120222023202420252026
Net debt ($)
2017201820192020202120222023202420252026
Share buybacks ($)
2017201820192020202120222023202420252026
Return on assets (%)
-47.40% -3.50% -10.00% -6.40% -14.10% -134.00% -68.10% -54.20% -2162.70% -35.80% 2017201820192020202120222023202420252026
Free cash flow margin (%)
-10173.60% 2017201820192020202120222023202420252026
Debt / equity (×)
2017201820192020202120222023202420252026
EPS ($)
-$2.16 -$0.71 -$0.91 -$86.27 -$1.06 2017201820192020202120222023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating margin-16729.4%—————————
Net margin-6852.0%—————————
FCF margin-10173.6%—————————
Return on assets-35.8%-2162.7%-54.2%-68.1%-134.0%-14.1%-6.4%-10.0%-3.5%-47.4%
Return on equity39.5%833.8%-67.0%-85.3%-156.2%-15.3%-6.9%-10.4%-4.0%-139.8%
Current ratio0.110.040.070.231.4811.086.7011.2518.041.40

Computed from company filings · US · as of 2026-06-30. Facts plus Stocktoria's own computed scores — not investment advice.